Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Shuttle Pharmaceuticals Holdings, Inc.
Market Cap
$2.33M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32M
EBITDA Margin
-100324.78%
TTM Avg
-75768.79%
3Y Avg
-56097.78%
5Y Avg
-38080.91%
Market Cap
$2.37M
EBITDA Margin
-776.30%
TTM Avg
-1492.64%
3Y Avg
-21514.87%
5Y Avg
-21514.87%
Market Cap
$2.49M
EBITDA Margin
-372.74%
TTM Avg
-308.17%
3Y Avg
-306.11%
5Y Avg
-396.88%
Market Cap
$2.52M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.55M
EBITDA Margin
-163.38%
TTM Avg
-126.27%
3Y Avg
-20964.27%
5Y Avg
-20964.27%
Market Cap
$2.06M
EBITDA Margin
-866.57%
TTM Avg
-750.00%
3Y Avg
-6212.81%
5Y Avg
-4728.90%
Market Cap
$2.61M
EBITDA Margin
-129.25%
TTM Avg
-125.71%
3Y Avg
-160.72%
5Y Avg
-184.50%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | $2.33M | N/A | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -100324.78% | -75768.79% | -56097.78% | -38080.91% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -776.30% | -1492.64% | -21514.87% | -21514.87% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.40M | N/A | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.49M | -372.74% | -308.17% | -306.11% | -396.88% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.52M | N/A | N/A | N/A | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | -163.38% | -126.27% | -20964.27% | -20964.27% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.06M | -866.57% | -750.00% | -6212.81% | -4728.90% |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | -129.25% | -125.71% | -160.72% | -184.50% |
| iSpecimen Inc. (ISPC)vs › | $2.72M | -375.69% | -244.00% | -166.51% | -121.60% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
